Frances Sun, MD
Geriatric Medicine · San Jose
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sun’s office at (408) 995-5453 to ask if they take your plan before you enroll.
California Medical Board record
Licence G58850 · Delinquent
Licence status: Delinquent · since 1986 · expires 2026-02-28 · Washington University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$275,458 in 2024
Medicaid paid $275,458 for 2,691 billed services this clinician did in 2024, up to 134 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,032 | $262,008 |
| Short return visit (20+ min) | 1,104 | $8,949 |
| Return visit (30+ min) | 462 | $3,922 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 51 | $570 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 21 | $6 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 21 | $4 |
| 2024 | 2,691 | 6 | 134 | $275,458 |
| 2023 | 3,641 | 7 | 184 | $334,766 |
| 2022 | 2,821 | 6 | 141 | $240,917 |
| 2021 | 5,662 | 11 | 218 | $531,573 |
| 2020 | 5,573 | 14 | 238 | $515,600 |
| 2019 | 3,212 | 7 | 183 | $318,241 |
| 2018 | 1,299 | 5 | 174 | $187,244 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,352 | $328,914 |
| Short return visit (20+ min) | 1,450 | $2,880 |
| Return visit (30+ min) | 628 | $2,143 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 70 | $639 |
| Short return visit | 110 | $144 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 16 | $44 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 15 | $2 |
2022
| Clinic visit/encounter, all-inclusive | 1,014 | $235,963 |
| Short return visit (20+ min) | 1,203 | $3,019 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 121 | $718 |
| Return visit (30+ min) | 298 | $647 |
| Short return visit | 170 | $391 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 15 | $180 |
2021
| Clinic visit/encounter, all-inclusive | 2,232 | $523,217 |
| Short return visit (20+ min) | 2,066 | $4,681 |
| Short return visit | 1,077 | $1,968 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 152 | $879 |
| TD VACC NO PRESV 7 YRS+ IM | 23 | $364 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 21 | $350 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 32 | $100 |
| Bilateral quantitative screening test of visual acuity | 15 | $8 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 18 | $6 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 13 | $0 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 13 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,222 | $508,286 |
| Short return visit (20+ min) | 1,999 | $4,830 |
| Short return visit | 724 | $1,582 |
| Return visit (30+ min) | 94 | $461 |
| Pure tone audiometry (threshold); air only | 27 | $195 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 29 | $120 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 25 | $100 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 57 | $18 |
| Bilateral quantitative screening test of visual acuity | 17 | $8 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 17 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 152 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 25 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,378 | $312,058 |
| Short return visit (20+ min) | 1,165 | $4,134 |
| Short return visit | 362 | $956 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 123 | $633 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 31 | $331 |
| Return visit (30+ min) | 49 | $128 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 104 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 819 | $182,997 |
| Short return visit (20+ min) | 438 | $3,628 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 14 | $270 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 13 | $240 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 15 | $109 |
Money from drug and device companies
$12 in 2021
A payment is not proof that care is biased.
| Meridian Bioscience | None | $12 | 1 payment
|
See the published payment
| Meridian Bioscience | Meals · 2021-03-02 | None | $12 |
Professional record
- NPI
- 1538245105
- Licence
- CA G58850California G58850: Delinquent · expires 2026-02-28
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QG0300X (207QG0300X)
- Mailing address
- 455 Oconnor Dr, Ste 210, San Jose, CA, 95128
- NPI first listed
- 2006-10-27
- NPI last updated
- 2012-02-16
This is when the NPI record was last certified, not a medical board exam.